Zacks Investment Research
05 Jun 2026, 22:46 UTC · 2h ago
AbbVie (ABBV) Ascends While Market Falls: Some Facts to Note
Zacks Investment Research
05 Jun 2026, 22:46 UTC · 2h ago
Story key points
5 claims · impact-rated
AbbVie is projected to report a quarterly EPS of $3.79, representing 27.61% growth year-over-year. — Strong projected earnings growth typically acts as a catalyst for share price appreciation.
+0.40AbbVie's full-year earnings projections suggest a 43% increase in earnings per share compared to the prior year. — High annual growth forecasts indicate strong fundamental momentum for the stock.
+0.30AbbVie's stock outperformed the S&P 500, Dow, and Nasdaq in the most recent trading session. — Relative strength against major indices suggests short-term bullish sentiment for the ticker.
+0.10The Zacks Consensus EPS estimate for AbbVie has decreased by 0.12% over the past month. — Slight downward revisions in analyst estimates can signal a cooling of near-term expectations.
Continue reading
6 related stories
Top 3 movers · tap to explore
AbbVie is currently assigned a Zacks Rank #3 (Hold). — A 'Hold' rating suggests a neutral outlook with no immediate strong buy or sell signal.
+0.00Ticker attribution
Model heads
The company outperformed major indices in the recent session and is projected to show significant EPS and revenue growth.
Listed as the #2 most viewed stock over the last 7 trading days, indicating high investor interest.
Experienced significant growth in page views (59.43%), signaling increased interest.
Listed as the #1 most viewed stock over the last 7 trading days, indicating high investor interest.
High total page views and significant page view growth indicate strong investor interest.
Listed as the #7 most viewed stock over the last 7 trading days, indicating high investor interest.
Experienced a very high growth in page views (176.88%), signaling increased interest.
Listed as the #3 most viewed stock over the last 7 trading days, indicating high investor interest.
Experienced significant growth in page views (64.50%), signaling increased interest.
Experienced significant growth in page views (74.36%), signaling increased interest.
Listed as the #5 most viewed stock over the last 7 trading days, indicating high investor interest.
Experienced significant growth in page views (75.97%), signaling increased interest.
No ticker relationship head found.
Early access
News Impact Screener scores every headline against the stocks it moves — before the chart reacts. Join the early-access list and get alerted the moment a story hits your tickers.
Impact vectors
3 dimensions · 9 clusters
Market reaction
10 bid · 0 offered
No stock impact ranking available yet.
Zacks Investment Research
2h ago
